The role of classical protein tyrosine phosphatases in diabetic kidney disease and therapeutic implications
Grace LeBleu, Fawaz G Haj · 2026
Read The role of classical protein tyrosine phosphatases in diabetic kidney disease and therapeutic implications by Grace LeBleu, Fawaz G Haj (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13536820.txt.
Description
Grace LeBleu and Fawaz Haj published this review in 2026 on diabetic kidney disease. About a third of people with diabetes develop the condition, and it remains a leading cause of kidney failure in the United States. The review centers on a family of enzymes called classical protein tyrosine phosphatases. These enzymes remove phosphate tags from proteins, counterbalancing the kinases that add them. Faulty tagging is a hallmark of the disease.
Of the hundred-plus phosphatase genes in humans, 38 are classical, and several are tied to damage in the kidney's filtering cells, vessels, tubules, and immune cells. The review sums up what each does in insulin signaling, cell structure, inflammation, and scarring. It then surveys drug strategies, from active-site blockers to allosteric agents and antibodies. The authors argue that aiming drugs at specific phosphatases could complement today's standard kidney care.
Catalog record
| CREATOR | Grace LeBleu, Fawaz G Haj |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 76 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |